PEDIATRIC CANCER RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,928,993
Investments
62%
Cash & Equivalents
23%
Other Assets
9%
Prepaid Expenses
4%
Receivables (Non-Related)
2%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$1,738,744
Grants Payable
56%
Deferred Revenue
19%
Other Liabilities
16%
Payables & Accruals
9%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,527,799
$663,371
-57%
Receivables (Non-Related)
$121,345
$69,831
-42%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$113,268
$111,860
-1%
Investments
$1,249,710
$1,824,083
+46%
Property, Plant, & Equipment (net)
$0
-
-
Other Assets
$293,814
$259,848
-12%
Total Assets
$3,305,936
$2,928,993
-11%
Liabilities
2023
2024
Change
Payables & Accruals
$247,474
$164,469
-34%
Grants Payable
$846,422
$965,847
+14%
Deferred Revenue
$164,181
$325,351
+98%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$317,896
$283,077
-11%
Total Liabilities
$1,575,973
$1,738,744
+10%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$1,729,963
$1,190,249
-31%
Net assets
2023
2024
Change
Net assets
+$1,729,963
+$1,190,249
-31%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)